Scholars Central

Conference abstractPublished 23 Jul 2018

Efficacy and tolerability of fixed dose combination of nadifloxacin and adapalene gel for the treatment of acne vulgaris: A phase III randomized multicenter study in India

Authors: Bela Shah, Rishi Jain, Agam Shah, Vaibhavi Kapatkar, Roheet Rathod, Salman Motlekar, Lyndon Dsouza

J. Medical College, India; Wockhardt Ltd, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Acne vulgaris is a chronic inflammatory disease. The multifactorial etiology of acne vulgaris makes it challenging to treat. Antimicrobials should be combined with topical retinoids for greater clearing of lesions and shortened duration of antibiotic treatment. Aim: The present study compared the efficacy and safety of nadifloxacin and adapalene fixed dose combination (FDC) gel with adapalene monotherapy and nadifloxacin monotherapy. Method: It was a randomized, double blind, controlled, multicentre, phase III, parallel group study conducted in India. In this eightweek study, 318 patients with mild to moderate acne were randomly allocated to either of the three treatment groups; Group A (morning placebo, evening FDC; FDC of nadifloxacin 1% + adapalene 0.1%, n=106), Group B (morning placebo, evening adapalene 0.1%, n=106) and Group C (twice daily nadifloxacin 1% alone, n=106). The outcome variables included lesion counts, acne severity based on investigator global assessment (IGA) scale and quality of life (QOL) assessment. Adverse events (AEs) were recorded at every visit. Findings: At the end of the treatment, maximum mean reduction in inflammatory lesion counts were comparable in Group A (-11.1) in comparison to Group B (-8.9) and Group C (-8.5); p>0.05 for both. However, change from baseline in non-inflammatory lesion count at week eight was higher in Group A (-13.1) compared to Group B (-12.0); p=0.04 and Group C (-11.5), p =0.17. For acne severity, 61.7% of patients in Group A, 54.3% in Group B and 56% in Group C showed improvement. The maximum improvement in terms of quality of life (QOL) score was observed in Group A; with comparable results for the other group. Conclusion: Topical fixed dose combination of nadifloxacin 1% and adapalene 0.1% is effective in mild to moderate acne with good tolerability. Recent Publications: 1. Stein Gold L, Baldwin H E and Lin T (2017) Management of severe acne vulgaris with topical therapy. Journal of Drugs in Dermatology: JDD 16(11):1134â??8. 2. Kaur J, Sehgal V K, Gupta A K and Singh S P (2015) A comparative study to evaluate the efficacy and safety of combination topical preparations in acne vulgaris. International Journal of Applied and Basic Medical Research 5(2):106. 3. Shah B J, Sumathy T K, Dhurat R S, Torsekar R G, Viswanath V, et al. (2014) Efficacy and tolerability of topical fixed combination of nadifloxacin 1% and adapalene 0.1% in the treatment of mild to moderate acne vulgaris in Indian patients: a multicenter, open-labelled, prospective study. Indian Journal of Dermatology 59(4):385â??9. 4. S Choudhury, S Chatterjee, D K Sarkar and R N Dutta (2011) Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial. Indian Journal of Pharmacology 43(6):628. 5. Kobayashi M, Nakagawa T, Fukamachi K, Nakamura M and Tokura Y (2011) Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: a randomized study. The Journal of Dermatology 38(12):1163â??6.

Subjects

Dermatology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Clinical & Experimental Dermatology Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Dermatology Research
  • SubjectDermatology
  • BylineArticles whose byline prints “Bela Shah”
  • BylineArticles whose byline prints “Rishi Jain”
  • BylineArticles whose byline prints “Agam Shah”
  • BylineArticles whose byline prints “Vaibhavi Kapatkar”
  • BylineArticles whose byline prints “Roheet Rathod”
  • BylineArticles whose byline prints “Salman Motlekar”
  • BylineArticles whose byline prints “Lyndon Dsouza”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels